Adempas
NDC 50419-253, riociguat, tablet, film coated, from Bayer HealthCare Pharmaceuticals Inc..
- Product NDC
- 50419-253
- Status
- Listed
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204819
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50419-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIOCIGUAT2 mg/1
Pharmacologic classes
Guanylate Cyclase Stimulators [MoA]; Soluble Guanylate Cyclase Stimulator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50419-253-01 | 50419025301 | 90 TABLET, FILM COATED in 1 BOTTLE (50419-253-01) |
| 50419-253-03 | 50419025303 | 2 BLISTER PACK in 1 PACKAGE (50419-253-03) / 21 TABLET, FILM COATED in 1 BLISTER PACK |
| 50419-253-91 | 50419025391 | 9 TABLET, FILM COATED in 1 BOTTLE (50419-253-91) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7b57509a-3d5d-41d4-8fed-1471e26372a3
Use it
Look up 50419-253 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50419-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50419-253. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.